Publications by authors named "M Gutierrez-Valencia"
Objective: The objective of this study is to analyze the appropriateness of the indication for urinary catheterization (UC) in hospitalized patients and to analyze possible associated factors.
Methods: Cross-sectional observational study conducted in 15 hospitals. Patients over the age of 18 with UC were included in the study.
Article Synopsis
- A recent study evaluated the prevalence of potentially inappropriate medications (PIM) in hospitalized adults aged 75 and older across 16 hospitals in Spain.
- The study included 4,183 patients and found that 23.5% were prescribed PIMs, with a notable variation in prevalence between hospitals (10% to 42.5%).
- Benzodiazepines were the most common PIMs, and many patients continued their PIMs from pre-admission into the hospital; however, few were still prescribed at discharge, highlighting the need for better medication management for older adults.
Article Synopsis
- * Approximately 17.4% of residents used at least one strong anticholinergic medication, with significant variation across countries (from 1.3% in China to 27.1% in Italy).
- * The findings indicated higher usage among residents with cognitive impairment and those classified as most frail, suggesting the need for targeted deprescribing to minimize medication-related risks.
Background: Complexities in older patient care and frequent polypharmacy requires tailored tools, specific skills and interdisciplinary collaborations. Traditional disease-centered education often overlooks these issues. Despite digital gamification's relevance in health education, limited exploration exists for gamified platforms addressing polypharmacy, especially within comprehensive geriatric assessment (CGA).
View Article and Find Full Text PDFObjective: To determine the efficacy and safety of CAR-T therapy in the treatment of patients with hematologic malignancies, in comparison with other current therapies.
Design: A living systematic review.
Methods: We will include randomized trials evaluating the effect of CAR-T therapy versus other active treatments, hematopoietic stem cell transplantation, best supportive care or any other intervention in patients with hematologic malignancies.